FDA-cleared, non-invasive, drug-free technology now available to VA and federal healthcare providers, supported by education, demonstration, onboarding, and implementation resources for clinic-to-home use.
TAMPA, FL / ACCESS Newswire / July 16, 2026 / Neuro20 Technologies, a veteran-founded Neurological Care Technology company, today announced that the Neuro20 PRO System is now available to Veterans Affairs facilities and other authorized federal healthcare providers through a federal procurement pathway.
The milestone supports Neuro20's broader mission to help veterans access continuous neurological care beyond traditional episodes of rehabilitation. For many veterans living with complex neurological, mobility, pain-related, and service-connected conditions, the need for support does not end when structured therapy becomes limited, reduced, or concludes.
Rehabilitation is episodic. Care is continuous.
At Neuro20, this gap is known as the Care Cliff - the point where formal rehabilitation slows down or stops, while the veteran's need for continued care, functional support, and long-term engagement remains. Neuro20 was developed to help bridge that gap through technology designed to extend professionally supervised neurological care from the clinic into the home.
"This is deeply personal to me," said Dennis "DJ" Schmitt, Founder and CEO of Neuro20 Technologies. "I live with the long-term effects of my own service-related injuries, and Neuro20 has made a meaningful difference in my life. From the beginning, one of our goals was to help veterans who may benefit from this technology have the opportunity to access it."
The federal access initiative is being advanced through Neuro20's partnership with Affirmative Solutions, LLC, an established Service-Disabled Veteran-Owned Small Business (SDVOSB) specializing in government contract selection, acquisition, and management services within the healthcare sectors of federal procurement agencies.
Supporting Clinical Implementation
Neuro20 recognizes that meaningful access requires more than product availability. For VA care teams, especially when considering home-use technology, evaluation, education, patient fit, onboarding, and support are critical.
Neuro20's VA-focused implementation model includes clinical education, product demonstrations, patient evaluation, implementation discussions, and virtual or in-person onboarding support when appropriate.
This approach helps care teams assess not only the technology itself, but also how it may fit into patient selection, clinical workflows, home-use readiness, provider training, and long-term engagement.
The Neuro20 PRO Home Care System supports clinician-directed continuation
of care beyond traditional rehabilitation settings. Scan the QR code to view a full patient-use video.
As implementation expands, Neuro20 will continue working with clinicians, rehabilitation professionals, veterans, and federal healthcare stakeholders to support education, evidence generation, and the responsible integration of continuous neurological care technologies across clinical and home-based settings.
A Non-Invasive, Drug-Free Technology Platform
The Neuro20 PRO System is an FDA-cleared, non-invasive, drug-free technology platform designed to support clinician-directed care for complex neurological, neuromuscular, mobility, and rehabilitation needs.
The system uses Whole-Body Electrical Neuromuscular Modulation to activate targeted muscle groups through an integrated Smart Suit, allowing trained providers to deliver controlled, full-body stimulation protocols during functional movement, therapeutic exercise, and rehabilitation activities.
Veterans may face overlapping challenges involving neurological injury, chronic pain, muscle weakness, spasticity, mobility limitations, deconditioning, and long-term functional decline. As healthcare teams continue seeking approaches that can complement existing care while reducing unnecessary reliance on pharmaceutical interventions, Neuro20 offers a technology platform designed to support multiple FDA-cleared therapeutic indications within a clinician-directed model of care.
Extending Care From Clinic to Home
The Neuro20 PRO platform is designed to help care teams support veterans across both supervised clinical use and home-based continuation of care.
A veteran uses the Neuro20 PRO System during functional rehabilitation.
The platform is designed to support clinician-directed care across clinical and home-based settings.
In clinical settings, trained healthcare providers can use the system to deliver individualized protocols while maintaining clinician oversight. The Neuro20 PRO Clinical System is also designed to support scalable implementation, allowing clinicians to supervise multiple patients when clinically appropriate.
When clinically indicated, the Neuro20 PRO Home Care System may allow providers to extend care beyond the clinic and support continued engagement between visits. Neuro20 and its partners can provide onboarding and support to help ensure that home-use systems are understood, appropriately implemented, and used as intended.
Every Neuro20 PRO Clinical System includes the expanded Neuro20 Protocol Book, featuring fifteen clinician-directed protocols across neurological and rehabilitation applications. The resource supports patient selection, treatment setup, protocol progression, and implementation consistency, helping providers integrate Neuro20 into existing clinical programs.
As part of its VA-focused initiative, Neuro20 also plans to develop additional implementation guidance and educational resources addressing appropriate use cases, patient selection, clinical workflows, home-care pathways, provider training, and responsible integration within federal healthcare settings.
Opening the Door to Continuous Neurological Care
Being available through a federal procurement pathway is an important step, but it is not the finish line. Neuro20's broader goal is to advance continuous, clinician-directed neurological care for veterans beyond traditional rehabilitation settings.
The company's message is clear: Being available to the VA is a milestone. Reaching veterans is the mission.
Neuro20's VA-focused efforts include clinical education, evidence review, patient evaluation, onboarding support, implementation guidance, and federal procurement resources. Additional information regarding the company's federal initiatives is available at gsa@neuro20.com.
For more information, visit www.neuro20.com.
About Neuro20 Technologies
Neuro20 Technologies is a veteran-founded Neurological Care Technology company advancing continuous, clinician-directed care across clinical and home-based settings. The company's FDA-cleared Neuro20 PRO platform integrates Whole-Body Electrical Neuromuscular Modulation, clinician-controlled technology, standardized rehabilitation protocols, connected care capabilities, and expanding clinical evidence to support healthcare providers and long-term patient engagement.
Neuro20's broader mission is to help bridge the Care Cliff by extending care beyond episodic rehabilitation and improving access to non-invasive, drug-free technologies that support long-term health, function, and quality of life for people living with neurological and mobility-related conditions.
Media and Company Contacts
Media, Marketing & Communications
Jana Schmitt, Founder/COO
jana@neuro20.com
Investor, Strategic Partnership & Distributor Inquiries
Dennis "DJ" Schmitt, Founder/CEO
dj@neuro20.com
VA / Federal Healthcare Evaluation & Procurement Inquiries
gsa@neuro20.com
SOURCE: Neuro20 Technologies
View the original press release on ACCESS Newswire